Blackstone invests $400m in HK-listed HEC Pharma via convertible bonds

Blackstone invests $400m in HK-listed HEC Pharma via convertible bonds

Photo: Bloomberg

U.S. private equity firm Blackstone Group LP has signed a deal to invest $400 million in Hong Kong-listed YiChang HEC ChangJiang Pharmaceutical Co. via convertible bonds, HEC said Wednesday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter